The vast majority of drugs currently approved for use in humans are either proteins or small molecules. Lying between the two in size, and integrating the advantages of both 1,2 , constrained peptides are an underexplored frontier for drug discovery. Naturally occurring constrained peptides, such as conotoxins, chlorotoxin, knottins and cyclotides, play critical roles in signalling, virulence and immunity, and are among the most potent pharmacologically active compounds known 3 . These peptides are constrained by disulfide bonds or backbone cyclization to favour binding-competent conformations that precisely complement their targets. Inspired by the potency of these compounds, there have been considerable efforts to generate new bioactive molecules by re-engineering existing constrained peptides using loop grafting, sequence randomization and selection 4 . Although powerful, these approaches are hindered by the limited variety of naturally occurring constrained peptide structures and the inability to achieve global shape complementarity with targets. There is need for a method of creating constrained peptides with new structures and functions that provides precise control over the size and shape of the designed molecules. A method with sufficient generality to incorporate non-canonical backbones and unnatural amino acids would enable access to broad regions of peptide structure and function space not explored by evolution.
calculations were carried out to identify sequences (including disulfide crosslinks) stabilizing each backbone conformation, and the designed sequence-structure pairs were assessed by determining the energy gap between the designed structure and alternative structures found in large-scale structure prediction calculations for the designed sequence. A subset of the designs in deep energy minima were then produced in the laboratory, and their stabilities and structures were determined experimentally.
Genetically encodable disulfide-constrained peptides
To design disulfide-stabilized genetically encodable peptides, we created a 'blueprint' specifying the lengths of each secondary structure element and connecting loop for each topology. Ensembles of backbone conformations were generated for each blueprint by Monte Carlobased assembly of short protein fragments 9 , or, in the case of HH and HHH topologies, by varying the parameters in backbone generating equations 11 . The backbones were scanned for sites capable of hosting disulfide bonds with near-ideal geometry, and one to three disulfide bonds were incorporated. Low-energy amino acid sequences were designed for each disulfide-crosslinked backbone using iterative rounds of Monte Carlo-based combinatorial sequence optimization while allowing the backbone and disulfide linkages to relax in the Rosetta all-atom force field (see Methods). Except for the EHEE topology, we performed no manual amino acid sequence optimization. Rosetta ab initio structure prediction calculations were carried out for each designed sequence, and synthetic genes were obtained for a diverse set of 130 designs for which the target structure was in a deep global free-energy minimum ( Fig. 2a, b ).
Disulfide bonds in peptides are unlikely to form in the reducing environment of the cytoplasm, so designs were secreted from Escherichia coli or cultured mammalian cells 12 (see Methods). Twentynine designs exhibited a redox-sensitive gel-shift, redox-sensitive high-performance liquid chromatography (HPLC) migration, and/ or a circular dichroism (CD) spectrum consistent with the designed topology (see Supplementary Document 3). All 29 contain at least one non-alanine hydrophobic residue on each secondary structure element contributing van der Waals interactions in the core, which are probably important for proper peptide folding. We chose one representative design from each topology for further biochemical characterization. The designed secondary structure architectures for each of the three classes of constrained peptides (genetically encodable disulfide-rich, heterochiral disulfide-crosslinked, and N-C cyclic) span most of the topologies that can be formed with four or fewer secondary structure elements. Arrows, β -strands; orange cylinders, right-handed α -helices; green cylinder, left-handed α -helix; red, loop segments containing d-amino acid residues. Genetically encodable peptides are given the prefix 'g' and a number to differentiate designs that share a common topology (peptide name at far left). a, Cartoon renderings of each design shown with rainbow colouring from the N terminus (blue) to the C terminus (red); disulfide bonds are shown as sticks. b, The energy landscape of each designed sequence was assessed by Rosetta structure prediction calculations starting from an extended chain (blue dots) or from the design model (orange dots); lower energy structures were sometimes sampled in the former because disulfide constraints were only present in the latter (r.e.u., Rosetta energy units; r.m.s.d., root mean square deviation from the designed topology). c, CD spectra at 20 °C (black lines), after heating to 95 °C (red lines), and upon cooling back to 20 °C (blue lines). Spectra collected with 2.5 mM TCEP are shown in green (MRE, mean residue ellipticity). d, CD spectra as a function of GdnHCl concentration (see key).
Since eight of the nine topologies contained four or more cysteine residues, we used multiple-stage mass spectrometry to investigate the disulfide connectivity. In all cases the data were consistent with the designed connectivity (see Supplementary Document 4) .
The stability of the designs to thermal and chemical denaturation was assessed by CD spectroscopy. Samples were heated to 95 °C (Fig. 2c ), or incubated with increasing concentrations of guanidinium hydrochloride (GdnHCl) (Fig. 2d ). The contribution of disulfide bonds to protein folding was assessed by incubating samples with a ~ 100-fold molar excess of the reductant tris(2-carboxyethyl)phosphine (TCEP). Designs gHEEE_02, gEEEH_04 and gEEEEEE_02 are resistant to both thermal and chemical denaturation, while design gHH_44 is resistant to thermal denaturation. gHEEE_02 contains three disulfide bonds, with each secondary structure element participating in at least one disulfide bond, and no two secondary structure elements sharing more than one disulfide bond. gEEEH_04 has two of three disulfide bonds linking the N-terminal β-strand to the C-terminal α -helix. gEEEEEE_02 consists of two antiparallel β -sheets packing against one another in a sandwich-like arrangement, with each β -sheet stabilized by a disulfide bond linking one terminus to its adjacent β -strand. gHH_44 consists of two α -helices with a single disulfide bond connecting the termini.
We crystallized design gEHEE_06 and determined the structure to a resolution of 2.09 Å ( Fig. 3 , Supplementary Table 2 -2). The crystals had three-fold non-crystallographic symmetry, and each protomer aligns to the design model with a mean all-atom root mean square deviation (r.m.s.d.) of 1.12 Å. All three of the designed disulfide bonds were well-defined by electron density (Extended Data Fig. 1 ), and rotamers of core residues exhibited excellent agreement with the design model. The protein was thermostable and completely resistant to chemical denaturation ( Fig. 2c, d ). While gEHEE_06 shares the short-chain scorpion toxin topology, the length of secondary structure elements and loops, and the position of the disulfide bonds, are entirely divergent from known natural peptides.
As crystallization efforts for other designs were unsuccessful (with phase-separation rather than protein precipitation observed), we expressed isotope-labelled peptides in E. coli, and determined structures by nuclear magnetic resonance (NMR) spectroscopy 13, 14 (see Methods) . Upfield chemical shifts of the cysteine β -carbons 15 (deposited in the Biological Magnetic Resonance Data Bank) confirmed the formation of the designed disulfide bonds. Design gEEHE_02, with one disulfide bond connecting the termini within the β -sheet and two between the α -helix and β -sheet, aligns to the NMR ensemble with a mean allatom r.m.s.d. of 1.44 Å. This design was impervious to both thermal and chemical denaturation (monitored by CD spectroscopy), and remained partially folded in the presence of TCEP. The final three designs are each composed of three secondary structure elements, with termini located at opposite ends of the molecule and two disulfide bonds connecting each terminus to the middle structural element or adjacent loop. gEEH_04 was less resistant than the others to thermal denaturation, but its NMR structure is nearly identical to the design model (mean all-atom r.m.s.d., 1.29 Å). gEHE_06, which contains a solvent-exposed two-strand parallel β -sheet (rare in natural protein structures 16 ), aligns to the NMR ensemble with an all-atom mean r.m.s.d. of 1.95 Å; it was thermally and chemically stable based on CD measurements, and remained folded in the presence of TCEP. gHHH_06 partially unfolds upon heating to 95 °C but returns to the folded state upon cooling; the design model aligns to the NMR ensemble with a mean all-atom r.m.s.d. of 1.74 Å. Taken together, the X-ray crystallographic and NMR structures demonstrate that our computational approach enables accurate design of protein main-chain conformation, disulfide bonds and core residue rotamers.
Synthetic heterochiral disulfide-constrained peptides
We next sought to design shorter disulfide-constrained peptides incorporating both l-and d-amino acids. We generalized the Rosetta energy function to support d-amino acids by inverting the torsional potentials used for the equivalent l-amino acids (see Methods and Supplementary Information), and sequence design algorithms were extended to enable mixed-chirality design. Since chemical synthesis is labour-intensive, we prioritized the development of automated computational screening techniques, supplementing Rosetta ab initio screening with molecular dynamics (MD) evaluation.
Large numbers of disulfide-constrained backbones for topologies HEE, EHE and EEH were generated by fragment assembly as described above for genetically encodable peptides. Sequences were designed (favouring d-amino acids at positions with positive mainchain φ dihedral angle values), and the resultant low-energy designs were evaluated using MD and ab initio structure prediction (Extended Data Fig. 2 ). For each topology, we selected a single, low-energy design (Extended Data Fig. 3 ) which underwent only small (< 1.0 Å r.m.s.d.) fluctuations in the MD simulations (Extended Data Fig. 4 ) and had a large energy gap in the structure prediction calculations. Selected peptides were chemically synthesized, and structurally characterized by NMR. In all three cases, the NMR spectra had well-dispersed, sharp Structures for gEHE_06, gEEH_04, gEEHE_02 and gHHH_06 were determined by NMR spectroscopy, and the structure of gEHEE_06 was determined by X-ray crystallography. a, C α traces of NMR ensembles, or superimposed members of the asymmetric unit, (grey), are aligned against the design model (rainbow). Disulfide bonds are shown with sidechain atoms rendered as sticks with sulfur atoms coloured yellow. b, Cartoon representation of the lowest energy conformer of each NMR ensemble or crystallographic asymmetric unit (grey) is shown aligned to the design model (rainbow). Two views of each structure are shown, rotated about the vertical axis by the indicated amount. Sidechain atoms of hydrophobic core residues are rendered as sticks.
peaks and secondary α proton ( 1 H α ) chemical shifts consistent with the secondary structure of the design model ( Supplementary Fig. 2-5 ). High-resolution NMR solution structures were determined for each of the designs (Supplementary Table 2 -3). NC_HEE_D1 is a 27-residue peptide with a d-proline, l-proline turn at the β -β junction; in this case, Rosetta re-identified a motif known previously to stabilize type II′ turns 17, 18 . The NMR structure closely matches the design model: the r.m.s.d. over all mainchain α carbon atoms (C α r.m.s.d) is 0.99 Å between the designed structure and the lowest-energy NMR model ( Fig. 4 , top row). NC_EHE_D1 is a 26-residue peptide crosslinked using two disulfide bonds with a d-arginine residue in the β -α loop and a d-asparagine residue as the C-terminal capping residue for the α -helix. The design model has a 1.9 Å C α r.m.s.d. to the lowestenergy NMR ensemble member, and a 0.68 Å C α r.m.s.d. to the closest member of the ensemble (Fig. 4 , middle row; the last two residues at the C-terminal vary considerably in the ensemble). NMR characterization of the NC_EEH_D1 design showed an unwound C-terminal α -helix adopting an extended conformation, differing from the design model (Extended Data Fig. 5 ). We hypothesized that substantial strain was introduced by the angle between the helix and the preceding strand, and by the disulfide bonds at both ends of the helix. A second design for the same topology, NC_EEH_D2, has a type I′ turn at the β -β connection and a different disulfide pattern. The NMR ensemble for NC_EEH_D2 is very close to the design model (0.86 Å C α r.m.s.d. to the lowest-energy NMR model; Fig. 4 , bottom row).
We explored the stability of the designed peptides using CD spectroscopy to monitor thermal and chemical denaturation. All three peptides are very thermostable; there is no loss in secondary structure for NC_HEE_D1 and NC_EEH_D2 at 95 °C, and only a small decrease for NC_EHE_D1 ( Fig. 4f ). Remarkably, NC_HEE_D1 does not denature in 6 M GdnHCl (Fig. 4g , top row). Treatment with TCEP causes unfolding of all three designs, highlighting the importance of disulfide bonds.
All of the designs described in this Article were created de novo without sequence information from natural proteins. Searches for similar sequences in the PDB and NCBI NR database using PSI-BLAST found significant alignments (e-value < 0.01) only for NC_EHE_D1 and gHH_44 ( Supplementary Table S1 -2 and S1-3). The NC_EHE_D1 sequence has weak similarity (e-value of 2 × 10 −4 ) to the zinc-finger domain of lysine-specific demethylase (PDB ID: 2MA5), but the aligned regions adopt different structures (Extended Data Fig. 6 ). The gHH_44 sequence has weak similarity (e-value of 0.001) to a single long helix in a leucine zipper (PDB ID: 4R4L), very different from the helical hairpin topology of the design.
Synthetic backbone-cyclized peptides
Next, we explored the design of peptides with cyclized backbones, which can increase stability and protect against exopeptidases 19 . To generate such backbones without dependence on fragments of known structures, we implemented a generalized kinematic loop closure 20,21 method (named 'GenKIC') to sample arbitrary covalently linked atom chains capable of connecting the termini. Each GenKIC chainclosure attempt involves perturbing multiple chain degrees of freedom, then analytically solving kinematic equations to enforce loop closure with ideal peptide bond geometry in the case of N-C cyclic peptides (see Methods, Supplementary Information, and Extended Data Fig. 7 ). Sequence design, backbone relaxation, and in silico structure validation using MD simulation and Rosetta ab initio structure prediction were carried out with terminal bond geometry constraints (Extended Data Fig. 2 ).
We synthesized cyclic peptides for three topologies (cEE, cHH and cHHH) and determined their structures by NMR spectroscopy. The 18-residue NC_cEE_D1 design has the cyclic anti-parallel β -sheet fold of natural θ -defensins, but with one disulfide bond (rather than three), and different turn types containing heterochiral sequences 22 . The lowest-energy NMR model has a C α r.m.s.d. of 1.26 Å to the designed structure. The variability in the curvature of the sheets across the NMR ensemble is similar to the variability observed in the structure prediction calculations ( Fig. 5 , top row). The 26-residue NC_cHH_D1 design, which has one disulfide bond linking the two α -helices, has a 1.03 Å C α r.m.s.d. from the lowest-energy NMR structure ( Fig. 5 , second row). The 22-residue NC_cHHH_D1 design has three short regions of α -helical structure and a single disulfide bond. The NMR structure of the design was again very close to the design model ( Fig. 5 , third row), with a C α r.m.s.d. of 1.06 Å to the lowest-energy NMR structure.
All three cyclic topologies were found to be extremely stable in thermal denaturation experiments, retaining CD signal when heated to 95 °C (Fig. 5f ). The CD spectra of NC_cHH_D1 and NC_cEE_D1 were nearly identical in 0 and 6 M GdnHCl, indicating that these peptides do not chemically denature ( Fig. 5g ; NC_cHHH_D1 showed some loss of secondary structure in 6 M GdnHCl). After treatment with TCEP, both NC_cHH_D1 and NC_cHHH_D1 lost secondary structure, but the CD spectrum of NC_cEE_D1 was not changed by reduction of the central disulfide bond (Fig. 5g , top row). Overall, the cyclic designs are exceptionally stable given their very small sizes.
Beyond natural secondary and tertiary structure
As a final test of the generality of the new design methodology, we designed a heterochiral, backbone-cyclized, two-helix topology with one non-canonical left-handed α -helix and one canonical right-handed α -helix (H L H R ) assembling into a tertiary structure not observed in natural proteins. As before, we validated designs by MD; however, for validation by ab initio structure prediction it was necessary to develop a new, GenKIC-based structure prediction protocol (see Extended Data Fig. 8 , Methods, and Supplementary Information) since the standard Rosetta ab initio structure prediction method utilizes fragments of native proteins, which typically do not contain left-handed helices. Our selected design for this topology, NC_H L H R _D1, is a 26-residue peptide with one d-cysteine, l-cysteine disulfide bond connecting the right-handed and left-handed α -helices. There is an excellent match between the NMR structure ensemble and design model (C α r.m.s.d., 0.79 Å) ( Fig. 6 ). As expected for the nearly achiral topology, the CD signal is very small (as observed for a previously studied two-chain, four-helix mixed d/l system 23 ), and no change was observable on heating to 95 °C. The secondary 1 H α chemical shifts also show nearly no change on heating to 75 °C ( Fig. 6g , Supplementary  Fig. 2-6 ), indicating that the peptide is thermostable. Successful design of this topology demonstrates that our computational methods are sufficiently versatile and robust to design in a conformational space not explored by nature.
Conclusions
The key advances in computational design presented here-notably the methods for designing constrained peptide backbones spanning a broad range of topologies and incorporating natural and non-natural building-blocks-enable high-accuracy design of new peptides with exceptional thermostability and resistance to chemical denaturation. All 12 experimentally determined structures are in close agreement with the design models, including one with helices of different chirality. Unlike the natural constrained peptide families, designed peptides are not limited to particular shapes, sizes, nucleating motifs, or disulfide connectivities; indeed, the sequences of these de novo peptides are quite different from those of any known peptides. Here we have focused on extending sampling and scoring methods to permit design with d-amino acids and cyclic backbones, but the new tools are fully generalizable to peptides containing more exotic building-blocks, such as amino acids with non-canonical sidechains 24 or non-canonical backbones 25 .
The hyperstable molecules presented in this study provide robust starting scaffolds for generating peptides that bind targets of interest using computational interface design 26 or experimental selection methods. Solvent-exposed hydrophobic residues can be introduced without impairing folding or solubility (Extended Data Figs 9 and 10, Supplementary Fig. 2-6 ), suggesting high mutational tolerance. Hence it should be possible to re-engineer the peptide surfaces, incorporating target-binding residues to construct binders, agonists or inhibitors. There has been considerable effort in both academia and industry to use small, naturally occurring proteins as alternatives to antibody scaffolds for library selection-based affinity reagent generation. Our genetically encoded designs offer considerable advantages as starting points for such approaches because of their high stability, small size and diverse shapes. Furthermore, having been designed exclusively to be robust and stable, they lack the often-destabilizing non-ideal structural features that arise in naturally occurring proteins from evolutionary selective pressure for a particular function. Similarly, the heterochiral designs described here provide starting points for split-pool and other selection strategies compatible with non-canonical amino acids.
Going beyond the re-engineering of our hyperstable designs to bind targets of interest, the methods developed in this Article can be used to design new backbones to fit specifically into target binding pockets. Such 'on-demand' target-specific scaffold generation is likely to yield scaffolds with considerably greater shape-complementarity than that of scaffolds generated without knowledge of the target. More generally, De novo design of constrained peptides can be divided into two main steps: backbone assembly and sequence design. Practically, our peptide design pipeline has been optimized to permit these two steps to be performed in immediate succession with a single set of inputs, with no need for export or manual curation of the generated backbones before the sequence design. (A third and final validation step is typically performed separately.)
For backbone assembly, we used two different approaches: disulfideconstrained topologies were sampled using a fragment assembly method, whereas backbone-cyclized peptide topologies were sampled using a fragment-independent kinematic closure-driven approach. Example scripts and command lines for each step in the design workflow are available in Supplementary Information. Backbone design using fragment assembly. In the case of disulfide-crosslinked designs, the topology was defined using a 'blueprint' that specifies secondary structure and torsion bins for each amino acid residue, the latter defined using the ABEGO alphabet system 7, 9 . The ABEGO nomenclature assigns a letter to each of five regions, or bins, in Ramachandran space. These bins correspond to the α -helical region (A), the β -sheet region (B), the region with positive mainchain φ dihedral angle values typically accessed by glycine (G), and the remainder of the Ramachandran space (E). (The fifth bin, O, represents residues with cispeptide bonds, and was not used here.) The blueprint is the input for a Rosetta Monte Carlo-based fragment assembly protocol 7, 9, 10, 27 that generates backbone conformations that match the blueprint architecture. Briefly, the fragment assembly protocol uses the defined blueprint to pick backbone fragments from a database of non-redundant high-resolution crystal structures. The insertion of fragments serves as the moves in a Monte Carlo search of backbone conformation space. For searches of the NC_EEH topology, loop types were limited to ABEGO bins EA and GG for the β β connection, and BAB and GBB for the α β connection. For sampling of the NC_EHE topology, β α connections were limited to GBB, BAB and AB, and α β connections were limited to GB, GBA and AGB. For sampling of the NC_HEE topology, α β connections were limited to BAAB, GB, GBA and AGB, and β β connections were limited to EA and GG. Backbone design using generalized kinematic closure. Although the fragment-based approaches described above are powerful, they are limited to conformations that are favoured by peptides composed primarily of l-amino acids. For N-C cyclic designs-NC_cHHH_D1, NC_cHH_D1, NC_cEE_D1 and NC_ cH L H R _D1-we chose to focus on fragment-independent methods that are better suited for exploring conformations that are accessible to only mixed d/l peptides. We therefore turned to generalized kinematic closure (GenKIC).
GenKIC-based sampling works by treating a peptide as a loop, or a series of loops to be 'closed' . The torsion values of an initial, 'anchor' residue are randomly selected; this residue is then fixed, and the rest of the peptide is treated as a loop-closure problem. The particular covalent linkages serve as a set of geometric constraints for loop closure. The GenKIC algorithm performs a series of usercontrolled perturbations to the torsion angles of the peptide chain, which inevitably disrupt the geometry of the closure points. GenKIC then mathematically solves for the value of six 'pivot' torsion angles that restore the geometry of the closure points and permit the loop to remain closed 20, 21, 28 . Because the algorithm can return up to sixteen solutions per closure attempt, filters are applied to eliminate solutions with pivot amino acid residues in energetically unfavourable regions of Ramachandran space or with other geometric problems, such as clashes with other residues. The 'best' solution is then chosen on the basis of the Rosetta score function 10 .
During the sampling steps, regions in the designed topology that were intended to form helices or sheets were initialized to ideal mainchain φ and ψ dihedral values, and were either kept fixed or perturbed by only small amounts (< 20°). In loop regions, the perturbation was carried out by drawing torsion values randomly, biased by the Ramachandran preferences of the amino acid residue. Glycine or d/l alanine were used for backbone sampling before design. The allowed range of the torsion value either covered the entire Ramachandran space or, in cases in which known loop ABEGO patterns could connect secondary structure elements, the mainchain torsion values were limited to those ABEGO bins. For example, during the design of the cEE topology, connection types were limited to the GG and EA torsion bins for the two-residue loops. Disulfide positioning. To design disulfide bonds, we evaluated all of the residue pairs with C β atoms separated by ≤ 5 Å for geometry suitable to disulfide bond formation 27 , selected backbones that could harbour disulfide bonds with nearideal geometry, and incorporated one to three disulfide bonds. To select an ideal disulfide configuration from the set of all sterically possible combinations of disulfide bonds for a given backbone, we ranked disulfide configurations according to their effect on the configurational entropy of the unfolded state. The reduction in the entropy of the unfolded state due to a set of multiple crosslinks was computed according to a random flight model using equation (6) in ref. 29 , with the volume of tolerance, Δ V, equal to 29.65 Å 3 and the link length, b, equal to 3.8 Å. This method has been implemented in the Rosetta software suite as DisulfidizeMover and DisulfideEntropyFilter, both of which are accessible to the RosettaScripts scripting language. Modifications to Rosetta to permit design of cyclic backbones and mixed d/l peptides. d-amino acid residues allow access to regions of conformational space that are normally accessed by only glycine. When placed correctly, they can provide greater rigidity than glycine, stabilizing glycine-dependent structural motifs and, thereby, the overall fold 30 . Because the Rosetta software suite has primarily been used for designing proteins consisting of the 19 canonical l-amino acids and glycine, a number of modifications were necessary to permit robust design of peptides containing mixtures of d-and l-amino acids. First, Rosetta's default scoring function (talaris2013 at the time of the work described here) was updated to permit d-amino acids to be scored with mirror symmetry relative their l-counterparts. Terms in the score function that are based on mainchain or sidechain torsion values were modified to invert d-amino acid torsion values before applying the equivalent l-amino acid potentials. The score-function terms that are based on interatomic distances required minimal changes. To permit energy minimization, score-function derivatives were also modified to invert torsion derivative values for d-amino acids. Rosetta's rotameric search algorithm, the packer, was modified to use l-amino acid rotamers with sidechain χ torsion values inverted for d-amino acid rotamer packing, and to update H α and C β positions appropriately when inverting residue chirality. Finally, we added an option to symmetrize the energy tables for the mainchain torsion preferences of glycine, which are asymmetric by default because they are based on statistics taken from the Protein Data Bank (PDB). (Glycine, in the context of l-amino acids only, occurs disproportionately in the positive-φ region of Ramachandran space, but should have no asymmetric preferences in a mixed d/l context.) Details of these modifications are described in Supplementary Information.
Because Rosetta has traditionally been used to build linear polymers, a number of core Rosetta libraries had to be modified to permit N-C cyclic geometry to be sampled and scored properly. The assumption that residue i is connected to residues i + 1 and i − 1, which is invalid for cyclic peptides, has been removed and replaced with proper look-ups of connected residue indices. Cyclic geometry support was tested by confirming that the circular permutations of cyclic peptide models score identically.
As of 11 March 2016, the default Rosetta score function has been changed to talaris2014, which re-weights a number of score terms and introduces one new term 31 . The talaris2014 score function has also been made fully compatible with d-amino acids and cyclic geometry. A newer, experimental score function, currently called beta_nov15, has also been made fully compatible with d-amino acids and cyclic geometry. Sequence design and filtering. Backbone assembly using fragment assembly or GenKIC was followed by a sequence design step. Sequence design was performed using the FastDesign protocol (see Supplementary Information) . This involves four rounds of alternating sidechain rotamer optimization (during which sidechain identities were permitted to change) and gradient-descent-based energy minimization. The best-scoring structure was taken from a minimum of three repeats of FastDesign (twelve rounds of rotamer optimization and minimization). Each amino acid position was sorted into a layer ('core' , 'boundary' or 'surface') on the basis of burial, and the layer dictated the possible amino acid types allowed at that position; for example, hydrophobic amino acid residues were only permitted at core positions. To favour more proline residues during sequence design, the reference weight for proline in the Rosetta score function was reduced by 0.5 units. Backbones were allowed to move during the relaxation steps. For each topology, about 80,000 structures were generated, and filtered on the basis of the overall energy per residue, score terms related to backbone quality and score terms related to the disulfide geometry. In a few cases for non-canonical peptides, a conservative mutation was manually introduced into a surface-exposed repeat sequence (for example, an arginine to break a poly-lysine sequence) to facilitate unambiguous NMR assignment. Rosetta-based computational validation. Typically, the number of designs that can be created in silico exceeds the number that can be produced and examined experimentally. We therefore used Rosetta to prune the list of designs, by one of two methods. For designs consisting of canonical amino acids, Rosetta's fragment-based ab initio algorithm 32 was used to predict the structure of a design given its amino acid sequence, and to determine whether the target structure was a unique minimum in the conformational energy landscape. Disulfide bonds were not allowed to form during these simulations; the designed disulfide bonds are intended to stabilize an already unique global energy minimum, rather than to create a global minimum that would not otherwise exist. Designs that incorporate short stretches of d-amino acids were also validated using Rosetta's fragment-based ab initio algorithm; the amino acid sequences of designs, with all d-amino acids mutated to glycine, were provided as input, and we allowed Rosetta to generate about 30,000 predicted structures as output. Unlike the standard ab initio protocol, we did not use secondary structure predictions in fragment picking. Additionally, the length of small and large fragments was set to 4 and 6 amino acid residues, respectively, instead of the default 3 and 9; we found that this produced better sampling for peptides. After conformational sampling, the d-amino acid positions were changed to their original identities and rescored. A small modification to the ab initio algorithm permitted it to build a terminal peptide bond for the N-C cyclic designs during the full-atom refinement stages of the structure prediction. Designs that showed no sampling near the design conformation or for which the design conformation was not the unique, lowest-energy conformation were discarded.
Because fragment-based methods are poorly suited to the prediction of structures with large amounts of d-amino acid content, such as NC_cH L H R _D1, we developed a new, fragment-free algorithm to validate these topologies. This algorithm, which we call simple_cycpep_predict, uses the same GenKIC-based sampling approach used to build backbones for design, with additional steps of filtering solutions on the basis of disulfide geometry, optimizing sidechain rotamers and gradient-descent energy minimization. Because the search space is vast, even with the constraints imposed by the N-C cyclic geometry and the disulfide bond(s), we further biased the search by setting mainchain torsion values for residues in the middle of the helices to helical values (a Gaussian distribution centred on φ = − 61°, ψ = − 41° for the α R helix and on φ = + 61°, ψ = + 41° for the α L helix); this is analogous to the biased sampling obtained by fragment-based methods, in which sequences with high helix propensity are sampled primarily with helical fragments. As with ab initio validation, designs showing poor sampling near the design conformation or poor energy landscapes were discarded. Molecular-dynamics-based computational validation. We carried out further molecular-dynamics-based validation of the designs for which the ab initio or simple_cycpep_predict algorithms predicted high-quality energy landscapes. Similarly to strategies described previously 33, 34 , we used multiple short and independent trajectories, starting with different initial velocities to analyse the conformational flexibility and kinetic stability of the designed peptides. Molecular dynamics simulations were performed in explicit solvent conditions using the AMBER12 package and Amber ff12sb force field 35 . A rectangular water box with a 10-Å buffer of TIP3P water 36 in each direction from the peptide was used for simulations. Sodium and chloride counterions were added to neutralize the system. The solvated system was minimized in two steps: solvent was first minimized for 20,000 cycles while keeping restraints on the peptide, followed by minimization of the whole system for another 20,000 cycles. At the start of simulations, the system was slowly heated from 0 K to 300 K under constant volume with positional restraints on the peptide of 10 kcal mol −1 Å −1 for 0.1 ns. For each selected peptide, 50 independent simulations starting with different initial velocities were performed. Each simulation started with the energy-minimized designed model, and was carried out for approximately 3.5 ns. Periodic boundary conditions were used with a constant temperature of 300 K using the Langevin thermostat 37 and a pressure of 1 atm with isotropic molecule-based scaling. A cut-off of 10 Å was used for the Lennard-Jones potential and the Particle Mesh Ewald method 38 to calculate long-range electrostatic interactions. The SHAKE algorithm 39 was applied to all bonds involving H atoms and an integration step of 2 fs was used for the simulations with amber12 PMEMD in the NPT ensemble. At the conclusion of the simulations, all the trajectories were analysed using the Amber12 package and VMD 40 . We looked for fluctuations in root-mean-square deviation (r.m.s.d.), and for the convergence (or lack thereof) to the designed structure among all the trajectories. The distribution of r.m.s.d. values at the end of all trajectories was also analysed, although the beginning two-thirds of each trajectory were discarded as a burn-in period. Molecular dynamics analyses for three designs of the same topology are shown in Extended Data Fig. 4 . Prediction of mutational tolerance. Because the designed peptides presented here are intended to be used as starting points for designing binders to targets of therapeutic interest, we sought to examine the extent to which the designs can tolerate mutations (such as those that must be introduced to create a binding surface). Owing to the computational expense of the mutational analysis, we focused on the NC_cH L H R _D1 design, mutating each position in sequence to each of alanine, arginine, aspartate and phenylalanine, and carrying out a full structure prediction simulation for each. These mutations covered each class of mutation (elimination of the sidechain, introduction of a positive or negative charge, introduction of a bulky aromatic sidechain or introduction of a small aliphatic sidechain). Mutations preserved chirality; that is, only d-amino acid to d-amino acid or l-amino acid to l-amino acid mutations were considered. Simulation runs were carried out on the Argonne Leadership Computing Facility's Blue Gene/Q supercomputer ('Mira') using a version of the Rosetta simple_ cycpep_ predict algorithm parallelized using the Message Passing Interface (MPI). The 127 prediction runs (each for a different mutation) each required approximately 20,000 CPU hours, and each produced about 25,000 sampled, closed conformations with good disulfide geometry. For each mutation considered, 50 trajectories were also carried out in which the mainchain was perturbed slightly and relaxed. The resulting collection of samples (from structure prediction and relaxation) was then used to calculate a goodness-of-energy-funnel metric, termed P near :
The value of P near ranges from 0 (a poor funnel with low-energy alternative conformations or poor sampling close to the design conformation) to 1 (a funnel with a unique low-energy conformation very close to the design conformation). N is the number of samples, and E i and r.m.s.d. i represent the Rosetta score and r.m.s.d. from the design structure of the ith sample, respectively. The parameter λ controls how close a state must be to the design if it is to be considered nativelike; this was set to 1 Å. Similarly, the parameter k B T (where k B is the Boltzmann constant and T is absolute temperature) governs the extent to which the shallowness or depth of the folding funnel affects the score; this was assigned a value of 1 Rosetta energy unit. The P near metric provided a basis for comparison for the mutations considered. Code availability. All the methods described here were implemented in the Rosetta software suite (http://www.rosettacommons.org). Rosetta software is freely available to academic and non-commercial users. Commercial licenses for the suite are available via the University of Washington Technology Transfer Office. Design protocols were implemented using the RosettaScripts interface available within the Rosetta software suite. Input files and command-line arguments for each step in our peptide design pipeline are available in Supplementary Information. Protein purification of genetically encodable disulfide-rich peptides. Genes of designed disulfide-rich peptides were cloned into the vector pCDB180 (which we have made available via Addgene) using Gibson Assembly 41 . Protein expression from E. coli was carried out using a large N-terminal fusion domain consisting of the native E. coli protein OsmY to direct periplasmic and extracellular localization 42 , a deca-histidine tag for protein purification, and the SUMO protein Smt3 from Saccharomyces cerevisiae to chaperone folding and provide a mechanism for scarless cleavage of the fusion from the designed protein 43 . Designed proteins were expressed from BL21* (DE3) E. coli (Invitrogen), and expression cultures were grown overnight with incubation at 37 °C and shaking at 225 r.p.m. Following expression via Studier autoinduction 44 , a periplasmic extract 45 was prepared by washing cells with 20% sucrose, 30 mM Tris-HCl pH 8.0, 1 mM EDTA pH 8.0, 1 mg ml −1 lysozyme. Protein was purified from the bacterial-conditioned medium and/or the periplasmic extract by immobilized metal-affinity chromatography (IMAC). During screening, fusion protein was purified from the bacterialconditioned medium of 50 ml cultures, which typically yielded 9 ± 4 mg of protein (before removal of the fusion protein). Protein expression from mammalian cells was carried out using the Daedalus 12 system, as previously described. With both purification systems, purified fusion proteins were cleaved by site-specific proteases, SUMO protease for E. coli and TEV protease for Daedalus, followed by a secondary IMAC step. The final designs were purified to homogeneity by reverse-phase high-performance liquid chromatography on an Agilent 1260 HPLC equipped with a C-18 Zorbax SB-C18 4.6 mm × 150 mm column. Solvent A (water + 0.1% TFA) and solvent B (acetonitrile + 0.1% TFA) were applied using a gradient of 0%-45% solvent B ramping linearly at a rate of 1% per minute. Synthesis and purification of non-canonical peptides. Linear and cyclic peptides were synthesized as previously described 46 . Briefly, peptides were synthesized using automated solid-phase peptide synthesis with the Fmoc (9-fluorenylmethyloxycarbonyl) strategy. Cyclic reduced peptides were obtained after cleavage of the sidechain-protected peptides from the resin, ligation of both termini and the cleavage of sidechain protecting groups. Linear reduced peptides were collected by simultaneously cleaving the sidechain-protecting groups and the resin from the peptides. All linear or cyclic reduced peptides were oxidized at room temperature in a buffer containing 0.1 M NH 4 HCO 3 , in which the peptide concentration was 0.25 mg ml −1 . After 48 h, the mixture was acidified with trifluoroacetic acid, loaded onto a semi-preparative column and purified by RP-HPLC. Mass spectrometry. Intact samples for each genetically encodable peptide were diluted in loading buffer with 0.1% formic acid and analysed on a Thermo Scientific Orbitrap Fusion Tribrid Mass Spectrometer via data-dependent acquisition. Liquid chromatography consisted of a 60-min gradient across a 15-cm column (internal diameter of 75 μ m ) packed with C 18 resin with a 3-cm kasil frit trap (internal ARTICLE RESEARCH diameter of 150 μ m ) packed with C 12 resin. For disulfide connectivity analysis, peptides were digested with sequencing-grade modified trypsin (Promega) at a 1:50 enzyme-to-substrate concentration for 1 h at 37 °C and then desalted via mixed-mode cationic exchange (MCX). Peptide samples were dried under vacuum and resuspended in 0.1% formic acid. Digested samples were analysed using data-dependent acquisition and targeted methods. Thermal and chemical denaturation experiments. Circular dichroism (CD) wavelength and temperature scans were recorded on an AVIV model 420 or Jasco J-1500 CD spectrometer. For thermal denaturation, peptides samples were prepared at 0.07-0.2 mg ml −1 final concentration in 10 mM sodium phosphate buffer (pH 7.0). Wavelength scans from 195 nm to 260 nm were recorded at 25 °C, 55 °C, 95 °C and again after cooling back to 25 °C. For chemical denaturation experiments, samples for each peptide were prepared in the presence of 0-6 M GdnHCl concentrations. The concentration of GdnHCl was measured by refractometry 47 . Peptide samples were also prepared in the presence of 2.5 mM TCEP (TCEP was pre-equilibrated to pH 7.0 before addition) and incubated for 3 h. Peptide concentrations were the same across all samples. Wavelength scans from 190 nm to 260 nm were recorded for each sample in a 0.1-cm cuvette. NMR analysis and structure determination of genetically encodable disulfiderich peptides. Agilent NMR spectrometers operating at 1 H resonance frequencies between 500 MHz and 750 MHz equipped with 1 H{ 15 N, 13 C} probes were used to acquire NMR data for gEHE_06, gEEHE_02, gEEH_04 and gHHH_06. The peptides were all uniformly 15 N-labelled. Peptide gEEH_04 was also about 10% labelled with 13 C. The peptides were dissolved in 50 mM sodium chloride, 20 mM sodium acetate, pH 4.8 (gEHE_06 and gEEHE_02) or 50 mM sodium phosphate, 4 μ M 4,4-dimethyl-4-silapentane-1-sulfonic acid, 0.02% sodium azide, pH 6.0 (gEEH_04 and gHHH_06). Final peptide concentrations ranged from 0.5 to 1.5 mM. The 1 H, 13 48, 49 . Because it was not economical to prepare uniformly 13 C-labelled peptides by autoinduction, established triple-resonance NMR backbone assignment protocols could not be used. Instead, the carbon resonances were assigned by analysing the 2D [ 1 H, 1 H] TOCSY spectra along with [ 13 C, 1 H] HSQC spectra (collected at natural 13 C abundance for gHHH_06, gEHE_06 and gEEHE_02). For gEEH_04, which was 10% fractionally 13 C-labelled, the assignments were complemented with HNCA spectra. NMR data were processed using the Felix2007 (MSI) and PROSA (v6.4) programs and were analysed using the programs Sparky (v3.115), XEASY or CARA. Proton chemical shifts were referenced to internal 2,2-dimethyl-2-silapentane-5-sulfonate (DSS), whereas 13 C and 15 N chemical shifts were referenced indirectly via gyromagnetic ratios. Chemical shifts, NOESY peak lists and time-domain NMR data were deposited in the BioMagResBank (for accession numbers see Supplementary Table 2-1) .
Isotropic overall rotational correlation times of 1.3-1.6 ns were inferred from averaged backbone 15 N spin relaxation times (http://www.nmr2.buffalo.edu/nesg. wiki), indicating that all peptides are monomeric in solution. The 1 H, 13 C and 15 N chemical shift assignments and NOESY peak lists were used for iterative structure calculations using the program CYANA (v2.1 and v3.97). Chemical shifts were used to derive dihedral φ and ψ angle constraints using the program TALOS+ 50 for residues located in well-defined regular secondary structure elements. For the final structure calculation, H-bond restraints 13 were also introduced for gEHE_06 and gEEHE_02, for slowly exchanging amide protons. The resulting ensemble of 20 CYANA conformers was refined by restrained molecular dynamics in an 'explicit water bath' using the program CNS (v1.3) 51 . Structural quality was assessed using the online Protein Structure Validation Suite (PSVS, v1.5) 52 . The structural statistics are summarized in Supplementary 13 C and 15 N HSQC. Solvent suppression was achieved using excitation sculpting. Spectra were processed using Topspin 2.1 then analysed using CcpNmr Analysis 53 . Chemical shifts were referenced to internal DSS.
Initial structures were generated using CYANA and were based on distance restraints derived from NOESY spectra recorded in both 10% and 100% D 2 O. The following restraints were also included: disulfide bonds; hydrogen bonds as indicated by slow D 2 O exchange and sensitivity of amide proton chemical shift to temperature; χ 1 restraints from ECOSY and NOESY data; and backbone φ and ψ dihedral angles generated using the program TALOS-N 54 . The final set of structures was generated within CNS 55 using torsion angle dynamics, refinement and energy minimization in explicit solvent, and protocols as developed for the RECOORD database 56 . Final structures were assessed for stereochemical quality using MolProbity 57 . X-ray crystallography. The gEHEE_06 peptide was purified by size-exclusion chromatography on an AKTA Pure using a GE HiLoad 16/600 Superdex 75-pg column, concentrated to 50 mg ml −1 , and crystallized by vapour diffusion over well solutions of 100 mM citrate (pH 3.5) and 25% PEG3350. Selected crystals were transferred to a cryo-solution of 100 mM citrate (pH 3.5), 20% PEG3350 and 15% glycerol. Diffraction data were collected on a Rigaku Micromax-007HF with a Saturn944+ CCD detector, and integrated and scaled with HKL-2000. Initial phases were determined by molecular replacement using Phaser 58 as implemented in the CCP4 software suite with coordinates derived from a Rosetta model for the scaffold. Molecular replacement found two molecules per asymmetric unit. This solution was iteratively refined with the program Refmac followed by model building with COOT, yielding crystallographic R values of R cryst = 39.9% and R free = 42.5%. On the basis of the Matthews' coefficient, the crystals should have contained three molecules per asymmetric unit to have a reasonable solvent content of 45%. At this point, positive electron density appeared that enabled manual positioning of a third molecule in the asymmetric unit and improvement of the R values to R cryst = 32.0% and R free = 34.9%. The model was further improved by including solvent molecules and TLS refinement. The quality of the final model was assessed using ProCheck and Molprobity (overall score: 100th percentile). The final model has been deposited in the PDB with accession code 5JG9. Crystallographic statistics are reported in Supplementary Table 2-2. Surface redesign. In an attempt to reduce solubility and enhance crystallization, we redesigned solvent-exposed residues of designs representing each major topological category (mixed α /β , all β -sheet and all α -helical). Two resurfaced variants were selected for each design, bearing between one and two solvent-exposed tyrosine residues. We then expressed and purified these resurfaced designs using Daedalus, all but one of which expressed in a soluble manner and exhibited a redox-sensitive migration time by reverse-phase HPLC. We were able to obtain diffracting protein crystals for only redesign gEEHE_2.1_02_0008, which diffracted to 2.90-Å resolution (Supplementary Table 2 -2). However, Matthews calculations predicted non-crystallographic symmetry with approximately 19 copies in the asymmetric unit, and attempts to phase the crystal by molecular replacement were unsuccessful, as were attempts to reproduce the crystal outside of the initial screen.
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Extended Data Figure 1 | Disulfide bonds are well defined by X-ray crystallography. An F o − F c omit-map is shown in blue, contoured at 4σ, for design gEHEE_06. Disulfide sulfur atoms were removed, and the omit-map was calculated following real-space refinement. The gEHEE_06 structure is shown in grey as a cartoon representation. Disulfide bonds are shown here as sticks, with sulfur atoms in yellow and carbon atoms in grey. Figure 2 | Flowchart of pipelines for designing noncanonical cyclic peptides. Inputs are shown in blue, RosettaScriptsautomated parts of the pipeline are in green, parts carried out by Rosetta standalone applications are pink (the fragment picker application) and purple (the various structure prediction applications), parts performed with MD software are yellow, and manual steps are grey. a, Fragmentdependent design workflow. Final computational validation was carried out using MD simulations and fragment-based Rosetta ab initio structure prediction. For peptides containing isolated d-amino acids, these residues were mutated to glycine for Rosetta ab initio structure prediction. b, Fragment-free design workflow using GenKIC. This approach permits design of non-canonical topologies like the mixed H L H R topology, which occurs in no known natural protein. The GenKIC-based structure prediction algorithm is described in Extended Data Fig. 7 and in Supplementary Information. GenKIC allows sampling of closed conformations of arbitrary chains of atoms, passing through canonical or non-canonical backbone or sidechain linkages. Bond length, bond angle and torsional degrees of freedom in the chain can be fixed, perturbed from a starting value by small amounts, set to user-defined values, or sampled randomly. The algorithm then solves for six torsion angles adjacent to three userdefined pivot atoms in order to enforce closure of the loop. The many solutions from the closure are then filtered internally, and each can be subjected to arbitrary user-defined Rosetta protocols and filtration in order to prune the solution list further. A single solution is selected from those passing filters by a user-defined selection criterion. This flowchart shows the steps in a single invocation of the algorithm; for sampling, a user may specify that the algorithm be applied any number of times. User inputs are shown in blue, steps carried out by the GenKIC algorithm itself are in green, steps carried out by Rosetta code external to the GenKIC algorithm are shown in yellow, and outputs are shown in salmon.
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